Oura passes 5.5 million rings as the category narrows to two
Sleep and recovery hardware is consolidating fast. That's good for buyers in the short run and worth watching in the long one.
Oura has sold 5.5 million rings to date, generated more than $1 billion in revenue in 2025 with sales forecast above $1.5 billion in 2026, and secured a $250 million credit line from JPMorgan, Goldman Sachs, Citigroup and Barclays. Together with Whoop's $10.1 billion valuation, the sleep-and-recovery category now has two clear financial leaders.
The facts, in brief
| Rings sold | 5.5 million to date |
| 2025 revenue | More than $1 billion |
| 2026 forecast | Above $1.5 billion |
| Credit line | $250 million — JPMorgan, Goldman Sachs, Citigroup, Barclays |
| Applandica score | 84/100 — highest in our sleep category |
What consolidation buys you
In the short term, quite a lot. Scale is why Oura could fund the validation work behind its sleep algorithm — 96 participants and 421,045 scored epochs against polysomnography is an expensive study, and small companies don't run them. It's also why the app keeps shipping and why support answers.
Our sixth scoring axis, staying power, exists because three health apps in our database shut down in twelve months and took user data with them. On that axis, a company with $1 billion in revenue and a bank facility is a materially safer place to keep four years of your sleep history.
What it costs you later
The usual thing: pricing power. Two dominant players with strong retention and no serious third option is not a configuration that produces cheaper subscriptions. We've tracked list prices monthly since June 2025 precisely because this pattern repeats — categories consolidate, then quietly reprice.
Oura's membership is currently $5.99 a month or $69.99 a year on top of $349 hardware. That's defensible today. It's worth watching what it looks like in 2028.
rings sold, on more than $1 billion of 2025 revenue. Scale is what pays for validation studies — and what eventually pays for price rises.Company figures, 2026
Applandica's read
Ian Stemberg · Co-founder & CEOI find it hard to be cynical about this one. Oura earned its position by being the most accurate device in its category and by publishing the evidence, which is exactly the behaviour we say we want.
The thing I'd flag for readers isn't about Oura at all. It's that a two-horse category is a fragile place to have your data. Both leaders now have strong incentives to keep you inside, and the practical protection against that is unglamorous: export your history once a quarter and keep the file. Oura makes that genuinely easy, which is one of the reasons it scores 84.
Frequently asked questions
How many Oura rings have been sold?
5.5 million to date, with more than $1 billion in 2025 revenue and sales forecast above $1.5 billion in 2026.
Is Oura profitable enough to stick around?
Its financial position is among the strongest in consumer health hardware — over $1 billion in revenue plus a $250 million credit line from four major banks. On our staying-power axis it scores 9.3 out of 10.
Should I worry about wearables consolidating?
Not for reliability — scale funds validation and support. The medium-term risk is pricing power in a category with two dominant players. Export your data periodically regardless of which you use.
Sources
- eMarketer — Oura trends and statistics. Accessed 1 Sep 2026
- Athletech News — Wearable makers eye healthcare and new innovations. Accessed 1 Sep 2026
FTC sues Hims & Hers over health data sent to Meta and Snap
The complaint pairs the two failures we log most often — advertising trackers on sensitive health data, and a…
AnalysisFDA steps back from wearables and AI health software
A January guidance shift means many wearables and AI health tools can reach the market without formal device review.…